Advertisement · 728 × 90
#
Hashtag
#TyrosineKinase
Advertisement · 728 × 90
Post image

This review surveys #oncogenic #GeneFusions—particularly #TyrosineKinase fusions—examines detection methods, highlights targeted therapies, and underscores the importance of identifying fusion‑positive cancers. @gumedcenter.bsky.social

#OpenAccess #STTT: doi.org/10.1038/s413...

1 0 0 0
Post image

High-frequency gain-of-function PTK2/FAK splicing alternatives in SCLC are associated with elevated #TyrosineKinase activity, sensitivity to FAK inhibitors, and poor #Prognosis, highlighting their therapeutic potential.

#OpenAccess: doi.org/10.1038/s413...

0 0 0 0
Post image

RDAA, an #oncogenicdriver in non-mutated #NSCLC, demonstrates strong sensitivity to #FDA-approved #ALKinhibitors, highlighting a promising therapy option for patients lacking #TyrosineKinase mutations. @mdanderson.bsky.social

#STTT #OpenAccess: doi.org/10.1038/s413...

0 0 0 0
Screenshot of Graphical Abstract with heading that reads "INFANTILE MYOFIBROMATOSIS"

Screenshot of Graphical Abstract with heading that reads "INFANTILE MYOFIBROMATOSIS"

Novel germline intronic PDGFRB variant associated with infantile myofibromatosis is resistant to #targetedtherapy with imatinib bit.ly/3CpK32q #personalizedmedicine #tyrosinekinase

1 2 0 0

New @biorxivpreprint about our collaboration with the Gherardi group @unipv for #structuralbiology studies on MET receptor #tyrosinekinase and HGF mimic agonists #structuralbiology @DBB_UniPV x.com/biorxivpreprint/status/1...

0 0 0 0